Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)
Xiaolu Zhang, Ziyu Wang, Yujia Zheng, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 4
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

NLRP inflammasomes in health and disease
Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Combination therapies and other therapeutic approaches targeting the NLRP3 inflammasome and neuroinflammatory pathways: a promising approach for traumatic brain injury
Zana Montazeri-Khosh, Ahmad Ebrahimpour, Mina Keshavarz, et al.
Immunopharmacology and Immunotoxicology (2025), pp. 1-17
Closed Access | Times Cited: 2
Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms
Xuehui Fan, Jianyang Cao, Mingxia Li, et al.
Advanced Science (2024) Vol. 11, Iss. 14
Open Access | Times Cited: 12
Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging
Gérald J. Prud’homme, Qinghua Wang
Cells (2024) Vol. 13, Iss. 17, pp. 1413-1413
Open Access | Times Cited: 10
Microglial NLRP3 Inflammasomes in Alzheimer’s Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics
Gunel Ayyubova, Leelavathi N. Madhu
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Non-coding RNAs affecting NLRP3 inflammasome pathway in diabetic cardiomyopathy: a comprehensive review of potential therapeutic options
Elahe Radmehr, Niloufar Yazdanpanah, Nima Rezaei
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Ketogenic Diets for Body Weight Loss: A Comparison with Other Diets
Damian Dyńka, Łukasz Rodzeń, Mateusz Rodzeń, et al.
Nutrients (2025) Vol. 17, Iss. 6, pp. 965-965
Open Access | Times Cited: 1
From Innate Immunity to Metabolic Disorder: A Review of the NLRP3 Inflammasome in Diabetes Mellitus
Iris Maria Nițulescu, George Ciulei, Angela Cozma, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6022-6022
Open Access | Times Cited: 22
Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Giacoma Galizzi, Marta Di Carlo
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8586-8606
Open Access | Times Cited: 18
Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 17
Mechanisms of NLRP3 inflammasome activation and the development of peptide inhibitors
Ye Tao, Weiyan Tao, Xiaoyi Chen, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 1-13
Closed Access | Times Cited: 17
The Past and Future of Inflammation as a Target to Cancer Prevention
Laura Antonucci, Michael Karin
Cancer Prevention Research (2024) Vol. 17, Iss. 4, pp. 141-155
Closed Access | Times Cited: 7
Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options
Sara Bindoli, Chiara Baggio, Andrea Doria, et al.
Drugs (2024) Vol. 84, Iss. 3, pp. 257-274
Open Access | Times Cited: 7
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist
Bryan Oronsky, Lori H. Takahashi, Richard D. Gordon, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 15
Crosstalk between hypoxia-induced pyroptosis and immune escape in cancer: From mechanisms to therapy
Seyed Mohammadmahdi Meybodi, Mahsa Ejlalidiz, Mohammadsadegh Rezaeian Manshadi, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 197, pp. 104340-104340
Open Access | Times Cited: 5
Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia
Xing Ye, Zi-jie Lin, Guang-hui Hong, et al.
Experimental Cell Research (2024) Vol. 438, Iss. 2, pp. 114061-114061
Closed Access | Times Cited: 5
Remote-controlled dexamethasone-duration on eye-surface with a micelle-magnetic nanoparticulate co-delivery system for dry eye disease
Qinxiang Zheng, Chaoxiang Ge, Kexin Li, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3730-3745
Open Access | Times Cited: 5
Unraveling the role of NLRP3 inflammasome in allergic inflammation: implications for novel therapies
Hui-Fei Lu, Yi-Chi Zhou, Tianyong Hu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
Miguel Á. Ortega, Diego De León-Oliva, Cielo García‐Montero, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer
Shaimaa Hamza, Ekaterina Garanina, Layaly Shkair, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 299-299
Open Access | Times Cited: 4
Harnessing Pyroptosis for Lung Cancer Therapy: The Impact of NLRP3 Inflammasome Activation
Rajiv Dahiya, Vijaykumar Sutariya, Sheeba Varghese Gupta, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155444-155444
Closed Access | Times Cited: 4
TLR/NLRP3 Inflammasome signaling pathways as a main target in frailty, cachexia and sarcopenia
Sanaz Keshavarz Shahbaz, Aida Mokhlesi, Roghaye Keshavarz Sadegh, et al.
Tissue and Cell (2025) Vol. 93, pp. 102723-102723
Closed Access
Revealing the dance of NLRP3: spatiotemporal patterns in inflammasome activation
Lee Spector, Naeha Subramanian
Immunometabolism (2025) Vol. 7, Iss. 1, pp. e00053-e00053
Open Access
The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review
Arezina Kasti, Konstantinos Katsas, Maroulla D. Nikolaki, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 171-171
Open Access
Nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing protein 3 inflammasome: From action mechanism to therapeutic target in clinical trials
Chunye Zhang, Shuai Liu, Yuxiang Sui, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top